Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1994-03-24
1996-04-09
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
43524027, 4353201, 5303873, 53038815, 5303883, 536 2353, C12N 510, C07K 1608, C07H 1512
Patent
active
055061320
ABSTRACT:
The invention provides human monoclonal antibodies specific for the glycoprotein II subunit of Varicella-zoster virus. Preferred antibodies exhibit strong complement-independent neutralizing activity, antibody dependent cellular cytotoxicity, and cross-reactivity with multiple strains of Varicella-zoster virus.
REFERENCES:
Sugano et al., Eur. J. Immunol., 17:359-64, 1987.
Ostberg et al., Hybridoma 2:361-367, 1983.
Morrison, Science 229:1202-1207, 1985.
Waldmann, Science 252:1657-1662, 1991.
Casale et al. Science 234:476-79, 1986.
Lake Philip
Ostberg Lars
Hutzell Paula K.
Sandoz Pharmaceuticals Corporation
LandOfFree
Human antibodies against varicella-zoster virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human antibodies against varicella-zoster virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human antibodies against varicella-zoster virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-138247